SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the 30th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2012, at the Westin St. Francis Hotel, San Francisco, beginning at 1:00 p.m. Pacific Standard Time.
Audio of the Fluidigm presentation will be simultaneously webcast at:
http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=FLDM.
The webcast will be archived for 90 days following the live presentation.
About Fluidigm
Fluidigm (NASDAQ: FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or chips, and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including nine different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.
For more information, please visit www.fluidigm.com.
“Fluidigm” and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.